Academic Journal
Q1Journal of Managed Care and Specialty Pharmacy
About Journal of Managed Care and Specialty Pharmacy
Journal of Managed Care and Specialty Pharmacy is a scholarly journal published by Academy of Managed Care Pharmacy (AMCP). SCImago 2025 lists it in Q1, with an SJR of 1.212 and H-index of 82.
Coverage: 2014-2026. Research categories: Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
Which drugs will Medicare negotiate next? Predicting selected drugs for Initial Price Applicability Year 2029
Kevin H. Li, Emma M. Cousin, Sean D. Sullivan
2026-09-23 · DOI: 10.18553/jmcp.2026.26277Economic advantage of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: A cost-per-responder evaluation
Santosh Gautam, Laura Morrison, Philippe Thompson-Leduc, Avani Samandur et al.
2026-09-11 · DOI: 10.18553/jmcp.2026.26127Payer coverage principles for precision medicine biomarker testing in oncology
Steven S. Kheloussi, Tianyi Wang, Kimberly Tsai, Dana McCormick et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9-b.s3Artificial intelligence–enabled causal estimate of Medicare drug plan integration in cancer care: A doubly robust machine learning instrumental variable analysis
Xiangxiang Jiang, Jayda Snipes, Jun Wu, Minghui Li et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1101AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression
Bridget Flavin, Gary Small, Charles Dragovich, Charles Dragovich et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9-a.s1Navigating uncertainty matters: Evaluating large language models for drug-drug interaction identification
Adeleine Tilley, Brian Murray, Kelli Henry, Xingmeng Zhao et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1076Who is responsible? A risk-stratified framework for pharmacist accountability in artificial intelligence–assisted managed care
Emine Gülce Byers, Chalissa Dibya Iranisha
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1130Automating cost-effectiveness models with agentic artificial intelligence: Case study and implications for value assessment
Rahul Mudumba, A. B. Modi, Kevin Mayo
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1090An informatics framework to harmonize electronic health record medication data for managed care analytics and artificial intelligence applications
Haowen Hsu, Gabriel Gazetta, Chi-Hua Lu, David M. Jacobs et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1052Advancing precision medicine access in oncology: Foundational considerations for managed care stakeholders
Steven S. Kheloussi
2026-09 · DOI: 10.18553/jmcp.2026.32.9-b.s1Natural language processing to develop a standardized lexicon for precision medicine in oncology
Tianyi Wang, Kimberly Tsai, Steven S. Kheloussi, Dana McCormick et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9-b.s2Comparative performance of large language models for appraising bias in real-world evidence studies
Chijioke M. Okeke, Regina Nechi, Javeria Khalid, Ibraheem M. Karaye et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1062Artificial intelligence in prior authorization and coverage decisions: A systematic review of methods, evidence gaps, and future implications for patient access
Taraneh Mousavi, Fadia Tohme Shaya, Catherine E. Cooke
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1135Molecules to market: A probabilistic artificial intelligence framework for predicting managed care adoption at the level of drug discovery
Rishi Sharma
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1122A pharmacist-overseen, artificial intelligence–enabled model for provider-side prior authorization: From burden to opportunity (PAVE-1)
Jorge A. Valedon Navarro, Rachel Reise
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1114Themed issue on artificial intelligence in managed care pharmacy
Amy M. Miller, Emily Ortman, Eberechukwu Onukwugha, Callahan Clark et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9.1050Key considerations when assessing clinical utility for biomarker testing: A checklist
Tianyi Wang, Kimberly Tsai, Steven S. Kheloussi, Dana McCormick et al.
2026-09 · DOI: 10.18553/jmcp.2026.32.9-b.s4Economic burden of immune-mediated and psychiatric comorbidities in patients with newly diagnosed vitiligo
David Rosmarin, Ahmed M. Soliman, Kent A. Hanson, Bang Truong et al.
2026-08-18 · DOI: 10.18553/jmcp.2026.26157Bundling medical and pharmacy benefits: Impact on medical costs
Eric S. Wilkinson, Guy David, Reetika Kumar, Philip A Saynisch et al.
2026-08 · DOI: 10.18553/jmcp.2026.32.8.945Equivalent effectiveness of a prescription binocular treatment for amblyopia in real-world practice
Eric D. Gaier, Brenda L. Bohnsack, Maria I. Bodack, Fatema Ghasia et al.
2026-08 · DOI: 10.18553/jmcp.2026.25336Reviews
Community Reviews
Version History
September 25, 2026 at 7:43 am
September 25, 2026